Nelson Obus's most recent trade in Lifecore Biomedical Inc was a trade of 19,506 Common Stock done . Disclosure was reported to the exchange on July 15, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jul 2025 | 19,506 | 138,193 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jul 2024 | 30,000 | 118,687 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 9,554 | 88,687 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2024 | 9,554 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 18,182 | 79,133 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 9,474 | 60,951 (0%) | 0% | - | Common Stock | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2023 | 9,474 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 9,554 | 9,554 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 9.50 per share. | 04 Jun 2022 | 7,059 | 51,477 (0%) | 0% | 9.5 | 67,061 | Common Stock |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2022 | 7,059 | 0 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2022 | 9,474 | 9,474 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jun 2021 | 7,059 | 7,059 | - | - | Restricted Stock Unit | |
| Lifecore Biomedical Inc | Nelson Obus | Director | Grant, award, or other acquisition of securities at price $ 11.64 per share. | 01 Jun 2021 | 8,303 | 44,418 (0%) | 0% | 11.6 | 96,647 | Common Stock |
| Lifecore Biomedical Inc | Nelson Obus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 8,303 | 0 | - | - | Restricted Stock Unit |